Lv61
2150 积分 2022-09-02 加入
Cutaneous B-Cell Lymphomas
6天前
已关闭
Primary Cutaneous Lymphoma: Recommendations for Clinical Trial Design and Staging Update from the ISCL, USCLC, and EORTC
6天前
已完结
The preclinical discovery and development of orelabrutinib as a novel treatment option for B-cell lymphoid malignancies
7天前
已完结
Orelabrutinib combined with rituximab and high-dose methotrexate as induction therapy in newly diagnosed primary central nervous system lymphoma
9天前
已关闭
Efficacy and safety of orelabrutinib combined with rituximab and high dose methotrexate in primary or secondary central nervous system diffuse large B-cell lymphoma: a retrospective analysis
9天前
已完结
Response-adapted ultra-low-dose 4 Gy radiation as definitive therapy of gastric MALT lymphoma: a single-centre, pilot trial
18天前
已完结
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
2个月前
已完结
Ibrutinib, rituximab, and lenalidomide in unfit or frail patients aged 75 years or older with de novo diffuse large B-cell lymphoma: a phase 2, single-arm study
2个月前
已完结
Treatment and survival for patients with localized primary ocular adnexal extranodal marginal zone lymphoma
2个月前
已完结
皖公网安备34019202002308
